New Elite Feature: Screen & Chart at the same time

Learn More
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 16 Total
AOS - A.O. Smith Corp - Stock Price Chart
Ticker
AOS [NYSE, S&P 500]
CompanyA.O. Smith Corp
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap7.72BEPS (TTM)3.75
P/E14.94EPS this Y-1.70%
Forward P/E13.46EPS next Y9.98%
PEG2.66EPS past 5Y12.66%
P/S2.03EPS next 5Y5.05%
P/B4.11EPS Q/Q-10.36%
Dividend2.59%Sales Q/Q-1.90%
Insider Own19.92%Inst Own84.49%
Insider Trans-0.01%Inst Trans1.73%
Short Float7.26%EarningsApr 30/b
Analyst Recom2.62Target Price70.80
Avg Volume1.54M52W Range56.77 - 81.86
May-15-26Downgrade JP Morgan Neutral → Underweight $60
A. O. Smith Corp. manufactures residential and commercial gas and electric water heaters, boilers, tanks, and water treatment products. It operates through the North America and Rest of World segments. The North America segment manufactures and markets comprehensive lines of residential and commercial gas and electric water heaters, boilers, and tanks. The Rest of World segment markets water treatment products in China, Europe, and India. The company was founded by Charles Jeremiah Smith in 1874 and is headquartered in Milwaukee, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DARRELL SCHUHOfficerMar 04 '26Proposed Sale74.391,10482,126Mar 04 04:14 PM
Schuh Darrell W.SVP; President & GM LochinvarMar 04 '26Sale74.391,10482,1262,201Mar 04 03:30 PM
Wheeler Kevin J.Executive ChairmanFeb 13 '26Option Exercise0.0036,0450136,692Feb 17 02:31 PM
STERN JAMES FExec VP, Corp Dev, Strat & SecFeb 13 '26Option Exercise0.006,8500103,134Feb 17 02:29 PM
Schuh Darrell W.SVP; President & GM LochinvarFeb 13 '26Option Exercise0.001,46003,651Feb 17 02:25 PM
AARD - Aardvark Therapeutics Inc - Stock Price Chart
Ticker
AARD [NASD, RUT]
CompanyAardvark Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap99.70MEPS (TTM)-3.21
P/E-EPS this Y-22.61%
Forward P/E-EPS next Y9.20%
PEG-EPS past 5Y-
P/S-EPS next 5Y0.03%
P/B1.15EPS Q/Q-130.51%
Dividend-Sales Q/Q-
Insider Own44.68%Inst Own29.72%
Insider Trans0.10%Inst Trans1.54%
Short Float10.06%EarningsMay 07/b
Analyst Recom2.25Target Price17.90
Avg Volume282.63K52W Range3.35 - 17.94
May-15-26Downgrade Morgan Stanley Equal-Weight → Underweight $3
Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sun NelsonChief Financial OfficerDec 11 '25Buy14.403,00043,200108,484Dec 12 08:30 PM
Lee Tien-LiChief Executive OfficerDec 11 '25Buy14.487,000101,3951,551,613Dec 12 08:30 PM
Lee Tien-LiChief Executive OfficerOct 15 '25Option Exercise4.241,2295,2111,544,613Oct 16 06:14 PM
Jones BryanChief Operating OfficerOct 15 '25Option Exercise4.241,2505,3001,250Oct 16 06:12 PM
Lee Tien-LiChief Executive OfficerSep 15 '25Buy9.6610,00096,6241,543,384Sep 16 06:15 AM
AEG - Aegon Ltd - Stock Price Chart
Ticker
AEG [NYSE]
CompanyAegon Ltd
CountryNetherlands
IndustryInsurance - Diversified
Market Cap12.62BEPS (TTM)0.71
P/E11.88EPS this Y58.29%
Forward P/E7.73EPS next Y-1.18%
PEG0.38EPS past 5Y95.22%
P/S0.39EPS next 5Y20.56%
P/B1.43EPS Q/Q-82.58%
Dividend6.06%Sales Q/Q-32.54%
Insider Own0.00%Inst Own10.80%
Insider Trans-Inst Trans-2.09%
Short Float0.17%EarningsFeb 19/b
Analyst Recom1.93Target Price8.84
Avg Volume5.83M52W Range6.64 - 8.48
May-15-26Downgrade Morgan Stanley Overweight → Equal-Weight
Aegon Ltd. is an international financial services company, which engages in the provision of investment, protection, and retirement solutions. It operates through the following segments: Americas, The Netherlands, United Kingdom, International, Asset Management, and Holding and Other Activities. The Americas segment covers business units in the United States and Brazil, including any of the units' activities located outside these countries. The Netherlands segment covers businesses activities from Aegon the Netherlands. The United Kingdom segment involves existing business and digital solutions. The International segment encompasses Hong Kong, Singapore, China, India, Indonesia, Hungary, Poland, Turkey, Romania, Spain, and Portugal. The Asset Management segment consists of Aegon Asset Management Global Platforms and strategic partnerships. The Holding and Other activities refers to financing, employee, and other administrative expenses of holding companies. The company was founded in 1844 and is headquartered in The Hague, the Netherlands.
ALLE - Allegion plc - Stock Price Chart
Ticker
ALLE [NYSE, S&P 500]
CompanyAllegion plc
CountryIreland
IndustrySecurity & Protection Services
Market Cap10.80BEPS (TTM)7.32
P/E17.16EPS this Y7.69%
Forward P/E13.16EPS next Y8.92%
PEG1.54EPS past 5Y16.90%
P/S2.60EPS next 5Y8.54%
P/B5.14EPS Q/Q-6.70%
Dividend1.70%Sales Q/Q9.74%
Insider Own0.42%Inst Own102.98%
Insider Trans-0.49%Inst Trans1.08%
Short Float4.17%EarningsApr 28/b
Analyst Recom2.25Target Price165.55
Avg Volume1.01M52W Range130.07 - 183.11
May-15-26Downgrade JP Morgan Overweight → Neutral $150
Allegion Plc engages in the provision of security products and solutions that keep people safe, secure, and productive. It operates through the Allegion Americas and Allegion International segments. The Allegion Americas segment offers security products, services, and solutions throughout North America. The Allegion International segment refers to security products, services, and solutions primarily throughout Europe, Asia and Oceania. The company was founded on May 9, 2013 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martens Robert C.SVP-Chief Innovation & DesignMay 07 '26Sale137.153,993547,6408,570May 11 12:18 PM
Robert MartensOfficerMay 07 '26Proposed Sale137.153,993547,658May 07 04:26 PM
MAIN SUEDirectorMar 11 '26Buy149.612,000299,2152,000Mar 12 02:56 PM
MIZELL STEVENDirectorFeb 19 '26Sale161.511,000161,5104,915Feb 20 02:08 PM
MIZELL STEVENDirectorFeb 18 '26Sale163.7940065,5165,915Feb 20 02:08 PM
ALMS - Alumis Inc - Stock Price Chart
Ticker
ALMS [NASD, RUT]
CompanyAlumis Inc
CountryUSA
IndustryBiotechnology
Market Cap2.91BEPS (TTM)-1.92
P/E-EPS this Y0.13%
Forward P/E-EPS next Y4.28%
PEG-EPS past 5Y-
P/S346.32EPS next 5Y13.32%
P/B5.13EPS Q/Q59.19%
Dividend-Sales Q/Q-89.99%
Insider Own34.97%Inst Own53.55%
Insider Trans12.18%Inst Trans5.02%
Short Float13.65%EarningsMay 14/a
Analyst Recom1.27Target Price39.90
Avg Volume1.36M52W Range2.76 - 30.60
May-15-26Downgrade H.C. Wainwright Buy → Neutral $25
Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AKKARAJU SRINIVASDirectorJan 09 '26Buy17.00588,2359,999,9951,853,488Jan 13 06:20 PM
Foresite Labs, LLC10% OwnerJan 08 '26Buy17.00411,7646,999,9885,702,536Jan 12 09:59 PM
Foresite Capital Management VI10% OwnerJan 08 '26Buy17.00411,7646,999,9885,702,536Jan 12 09:58 PM
Tananbaum James B.DirectorJan 08 '26Buy17.00411,7646,999,9885,702,536Jan 12 09:58 PM
AKKARAJU SRINIVASDirectorDec 05 '25Buy9.84186,3771,833,7601,265,253Dec 09 07:13 PM
CCAP - Crescent Capital BDC Inc - Stock Price Chart
Ticker
CCAP [NASD]
CompanyCrescent Capital BDC Inc
CountryUSA
IndustryAsset Management
Market Cap410.10MEPS (TTM)0.41
P/E27.41EPS this Y-12.71%
Forward P/E7.38EPS next Y-4.52%
PEG-EPS past 5Y-13.95%
P/S2.80EPS next 5Y-6.07%
P/B0.61EPS Q/Q-498.96%
Dividend13.68%Sales Q/Q-27.42%
Insider Own14.75%Inst Own55.68%
Insider Trans0.04%Inst Trans-
Short Float1.66%EarningsMay 13/a
Analyst Recom1.71Target Price14.36
Avg Volume207.32K52W Range11.80 - 16.29
May-15-26Upgrade B. Riley Securities Neutral → Buy $13.50
May-15-26Downgrade Oppenheimer Outperform → Perform
Crescent Capital BDC, Inc. is a traded business development company, which engages in investing in middle market companies located in the United States. The fund focuses on companies operating across a broad range of sectors. It provides financing in the form of secured debt including first lien, second lien debt, unsecured debt, mezzanine subordinated debt, and equity securities for buyout transactions. The firm acquires controlling interest. The company was founded on February 5, 2015 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lombard GerhardChief Financial OfficerNov 17 '25Buy13.342,00026,68334,284Nov 18 04:11 PM
Bouek KirillControllerAug 28 '25Buy15.672003,1331,057Aug 29 04:17 PM
Barrios RaymondManaging DirectorAug 25 '25Buy15.633,24550,71319,177Aug 26 05:22 PM
UFCW-Northern California Emplo10% OwnerMay 29 '25Sale15.31303,9804,653,9343,902,095Aug 18 05:39 PM
UFCW-Northern California Emplo10% OwnerJun 03 '25Sale14.90109,4291,630,4923,738,095Aug 18 05:39 PM
DOCS - Doximity Inc - Stock Price Chart
Ticker
DOCS [NYSE]
CompanyDoximity Inc
CountryUSA
IndustryHealth Information Services
Market Cap3.50BEPS (TTM)0.98
P/E19.29EPS this Y-5.73%
Forward P/E11.91EPS next Y11.16%
PEG1.70EPS past 5Y52.56%
P/S5.43EPS next 5Y6.99%
P/B3.58EPS Q/Q-67.50%
Dividend-Sales Q/Q5.12%
Insider Own29.77%Inst Own67.87%
Insider Trans-0.07%Inst Trans1.38%
Short Float13.10%EarningsMay 13/a
Analyst Recom2.16Target Price24.92
Avg Volume3.45M52W Range17.15 - 76.51
May-15-26Downgrade Barclays Overweight → Equal Weight $20
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sitaram SiddharthInterim PFO and PAOMay 11 '26Sale25.772,30959,50389,396May 13 04:10 PM
SIDDHARTH SITARAMOfficerMay 11 '26Proposed Sale25.772,30959,503May 11 04:01 PM
Wampler Kira SchererDirectorMay 07 '26Sale26.069,000234,54019,839May 08 06:00 PM
KIRA WAMPLERDirectorMay 07 '26Proposed Sale26.069,000234,540May 07 04:03 PM
Sitaram SiddharthInterim PFO and PAOApr 10 '26Sale21.092,42751,18586,705Apr 14 05:56 PM
FRMI - Fermi Inc - Stock Price Chart
Ticker
FRMI [NASD]
CompanyFermi Inc
CountryUSA
IndustryREIT - Specialty
Market Cap4.15BEPS (TTM)-
P/E-EPS this Y106.86%
Forward P/E5.66EPS next Y1513.11%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.82EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own61.48%Inst Own8.18%
Insider Trans-3.31%Inst Trans132.29%
Short Float14.82%EarningsMay 14/b
Analyst Recom1.44Target Price18.78
Avg Volume14.12M52W Range4.47 - 36.99
May-15-26Downgrade Evercore ISI Outperform → In-line $11
Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hamilton Charles LynnChief Site Development OfficerApr 08 '26Sale4.91375,9501,845,9145,924,050Apr 10 07:38 PM
Hamilton Charles LynnChief Site Development OfficerApr 09 '26Sale4.58398,1401,823,4815,525,910Apr 10 07:38 PM
Ortiz Blanes JacoboChief Operating OfficerApr 08 '26Sale4.91403,5451,981,4065,896,455Apr 10 07:38 PM
Ortiz Blanes JacoboChief Operating OfficerApr 09 '26Sale4.58427,3631,957,3235,469,092Apr 10 07:38 PM
Everson Miles E.Chief Financial OfficerApr 08 '26Sale4.91403,2051,979,73710,396,795Apr 10 07:37 PM
GAMB - Gambling.com Group Ltd - Stock Price Chart
Ticker
GAMB [NASD, RUT]
CompanyGambling.com Group Ltd
CountryUnited Kingdom
IndustryGambling
Market Cap84.23MEPS (TTM)-1.28
P/E-EPS this Y140.67%
Forward P/E3.48EPS next Y82.16%
PEG-EPS past 5Y-
P/S0.51EPS next 5Y-
P/B0.79EPS Q/Q-110.77%
Dividend-Sales Q/Q-0.48%
Insider Own41.17%Inst Own38.86%
Insider Trans0.06%Inst Trans-18.60%
Short Float8.75%EarningsMay 14/a
Analyst Recom1.44Target Price5.88
Avg Volume716.66K52W Range3.51 - 14.95
May-15-26Downgrade The Benchmark Company Buy → Speculative Buy $4
Gambling.com Group Ltd is a marketing company, which engages in the provision of digital marketing services for the online gambling industry. It focuses on iGaming and sports betting. The company was founded by Charles Gillespie and Kevin McCrystle on July 26, 2006 and is headquartered in St. Helier, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Monaghan EllenSVP PeopleApr 01 '26Option Exercise3.721,1754,3712,815Apr 24 03:36 PM
Mark Martin EliasCFOApr 15 '26Buy3.243,86012,506803,256Apr 22 02:23 PM
McCrystle Kevin RossCOOApr 15 '26Buy3.247382,3911,001,885Apr 22 02:21 PM
Gillespie CharlesCEOApr 15 '26Buy3.243,86012,506226,641Apr 22 02:20 PM
McCrystle Kevin RossCOOApr 06 '26Option Exercise3.8310,01138,3421,001,147Apr 08 11:20 AM
JSPR - Jasper Therapeutics Inc - Stock Price Chart
Ticker
JSPR [NASD]
CompanyJasper Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap23.80MEPS (TTM)-3.23
P/E-EPS this Y67.64%
Forward P/E-EPS next Y-16.83%
PEG-EPS past 5Y48.97%
P/S-EPS next 5Y40.56%
P/B7.00EPS Q/Q97.10%
Dividend-Sales Q/Q-
Insider Own13.62%Inst Own52.31%
Insider Trans0.00%Inst Trans-13.47%
Short Float11.25%EarningsMay 14/a
Analyst Recom2.00Target Price9.08
Avg Volume410.83K52W Range0.62 - 7.19
May-15-26Downgrade TD Cowen Buy → Hold
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WIGGANS THOMAS GDirectorSep 22 '25Buy2.4341,00099,63041,000Sep 24 04:01 PM
Lucas SvetlanaDirectorSep 22 '25Buy2.4320,00048,60020,000Sep 24 04:01 PM
MARTELL RONPresident and CEOSep 22 '25Buy2.4341,00099,63074,118Sep 24 04:01 PM
Shizuru Judith AnneDirectorSep 22 '25Buy2.4341,00099,630156,901Sep 24 04:01 PM
12